APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine System Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endocrine System Drugs Market Analysis and Forecast 2026-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchEndocrine System Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine System Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Endocrine System Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine System Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine System Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Endocrine System Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Endocrine System Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endocrine System Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endocrine System Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endocrine System Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Endocrine System Drugs include Sanofi, Merck, Eli Lilly, AbbVie, AstraZeneca and Novo Nordisk, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Endocrine System Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endocrine System Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Endocrine System Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endocrine System Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endocrine System Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endocrine System Drugs sales, projected growth trends, production technology, application and end-user industry.

Endocrine System Drugs Segment by Company

Sanofi

Merck

Eli Lilly

AbbVie

AstraZeneca

Novo Nordisk

Endocrine System Drugs Segment by Type

Thyroid Hormone Disorder Drugs

Human Growth Hormones

Diabetes Drug

Others

Endocrine System Drugs Segment by Application

Clinics

Hospitals

Medical Center

Others

Endocrine System Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine System Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine System Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine System Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Endocrine System Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Endocrine System Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine System Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endocrine System Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Thyroid Hormone Disorder Drugs Major Manufacturers Table 3. Human Growth Hormones Major Manufacturers Table 4. Diabetes Drug Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Endocrine System Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinics Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. Medical Center Major Manufacturers Table 10. Others Major Manufacturers Table 11. Endocrine System Drugs Industry Trends Table 12. Endocrine System Drugs Industry Drivers Table 13. Endocrine System Drugs Industry Opportunities and Challenges Table 14. Endocrine System Drugs Industry Restraints Table 15. Global Endocrine System Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Endocrine System Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Endocrine System Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Endocrine System Drugs Revenue Market Share by Region (2021-2026) Table 19. Global Endocrine System Drugs Revenue Market Share by Region (2027-2032) Table 20. Global Endocrine System Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 21. Global Endocrine System Drugs Sales by Region (2021-2026) & (K Pcs) Table 22. Global Endocrine System Drugs Sales by Region (2027-2032) & (K Pcs) Table 23. Global Endocrine System Drugs Sales Market Share by Region (2021-2026) Table 24. Global Endocrine System Drugs Sales Market Share by Region (2027-2032) Table 25. Global Endocrine System Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Endocrine System Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Endocrine System Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Endocrine System Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global Endocrine System Drugs Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 30. Global Endocrine System Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Endocrine System Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Endocrine System Drugs Manufacturers, Product Type & Application Table 33. Global Endocrine System Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Endocrine System Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Endocrine System Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Endocrine System Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Endocrine System Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Endocrine System Drugs Revenue Market Share by Type (2021-2026) Table 40. Global Endocrine System Drugs Revenue Market Share by Type (2027-2032) Table 41. Global Endocrine System Drugs Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 42. Global Endocrine System Drugs Sales by Type (2021-2026) & (K Pcs) Table 43. Global Endocrine System Drugs Sales by Type (2027-2032) & (K Pcs) Table 44. Global Endocrine System Drugs Sales Market Share by Type (2021-2026) Table 45. Global Endocrine System Drugs Sales Market Share by Type (2027-2032) Table 46. Global Endocrine System Drugs Price by Type (2021-2026) & (US$/Pcs) Table 47. Global Endocrine System Drugs Price by Type (2027-2032) & (US$/Pcs) Table 48. Global Endocrine System Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Endocrine System Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Endocrine System Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Endocrine System Drugs Revenue Market Share by Application (2021-2026) Table 52. Global Endocrine System Drugs Revenue Market Share by Application (2027-2032) Table 53. Global Endocrine System Drugs Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 54. Global Endocrine System Drugs Sales by Application (2021-2026) & (K Pcs) Table 55. Global Endocrine System Drugs Sales by Application (2027-2032) & (K Pcs) Table 56. Global Endocrine System Drugs Sales Market Share by Application (2021-2026) Table 57. Global Endocrine System Drugs Sales Market Share by Application (2027-2032) Table 58. Global Endocrine System Drugs Price by Application (2021-2026) & (US$/Pcs) Table 59. Global Endocrine System Drugs Price by Application (2027-2032) & (US$/Pcs) Table 60. Sanofi Company Information Table 61. Sanofi Business Overview Table 62. Sanofi Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 63. Sanofi Endocrine System Drugs Product Portfolio Table 64. Sanofi Recent Development Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 68. Merck Endocrine System Drugs Product Portfolio Table 69. Merck Recent Development Table 70. Eli Lilly Company Information Table 71. Eli Lilly Business Overview Table 72. Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 73. Eli Lilly Endocrine System Drugs Product Portfolio Table 74. Eli Lilly Recent Development Table 75. AbbVie Company Information Table 76. AbbVie Business Overview Table 77. AbbVie Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 78. AbbVie Endocrine System Drugs Product Portfolio Table 79. AbbVie Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 83. AstraZeneca Endocrine System Drugs Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Novo Nordisk Company Information Table 86. Novo Nordisk Business Overview Table 87. Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 88. Novo Nordisk Endocrine System Drugs Product Portfolio Table 89. Novo Nordisk Recent Development Table 90. North America Endocrine System Drugs Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Endocrine System Drugs Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Endocrine System Drugs Sales by Type (2021-2026) & (K Pcs) Table 93. North America Endocrine System Drugs Sales by Type (2027-2032) & (K Pcs) Table 94. North America Endocrine System Drugs Sales Price by Type (2021-2026) & (US$/Pcs) Table 95. North America Endocrine System Drugs Sales Price by Type (2027-2032) & (US$/Pcs) Table 96. North America Endocrine System Drugs Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Endocrine System Drugs Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Endocrine System Drugs Sales by Application (2021-2026) & (K Pcs) Table 99. North America Endocrine System Drugs Sales by Application (2027-2032) & (K Pcs) Table 100. North America Endocrine System Drugs Sales Price by Application (2021-2026) & (US$/Pcs) Table 101. North America Endocrine System Drugs Sales Price by Application (2027-2032) & (US$/Pcs) Table 102. North America Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Endocrine System Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. North America Endocrine System Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. North America Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 106. North America Endocrine System Drugs Sales by Country (2021-2026) & (K Pcs) Table 107. North America Endocrine System Drugs Sales by Country (2027-2032) & (K Pcs) Table 108. North America Endocrine System Drugs Sales Price by Country (2021-2026) & (US$/Pcs) Table 109. North America Endocrine System Drugs Sales Price by Country (2027-2032) & (US$/Pcs) Table 110. United States Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 111. Canada Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 112. Europe Endocrine System Drugs Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Endocrine System Drugs Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Endocrine System Drugs Sales by Type (2021-2026) & (K Pcs) Table 115. Europe Endocrine System Drugs Sales by Type (2027-2032) & (K Pcs) Table 116. Europe Endocrine System Drugs Sales Price by Type (2021-2026) & (US$/Pcs) Table 117. Europe Endocrine System Drugs Sales Price by Type (2027-2032) & (US$/Pcs) Table 118. Europe Endocrine System Drugs Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Endocrine System Drugs Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Endocrine System Drugs Sales by Application (2021-2026) & (K Pcs) Table 121. Europe Endocrine System Drugs Sales by Application (2027-2032) & (K Pcs) Table 122. Europe Endocrine System Drugs Sales Price by Application (2021-2026) & (US$/Pcs) Table 123. Europe Endocrine System Drugs Sales Price by Application (2027-2032) & (US$/Pcs) Table 124. Europe Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Endocrine System Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. Europe Endocrine System Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. Europe Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 128. Europe Endocrine System Drugs Sales by Country (2021-2026) & (K Pcs) Table 129. Europe Endocrine System Drugs Sales by Country (2027-2032) & (K Pcs) Table 130. Europe Endocrine System Drugs Sales Price by Country (2021-2026) & (US$/Pcs) Table 131. Europe Endocrine System Drugs Sales Price by Country (2027-2032) & (US$/Pcs) Table 132. Germany Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 133. France Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 134. U.K. Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 135. Italy Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 137. Nordic Countries Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 138. China Endocrine System Drugs Revenue by Type (2021-2026) & (US$ Million) Table 139. China Endocrine System Drugs Revenue by Type (2027-2032) & (US$ Million) Table 140. China Endocrine System Drugs Sales by Type (2021-2026) & (K Pcs) Table 141. China Endocrine System Drugs Sales by Type (2027-2032) & (K Pcs) Table 142. China Endocrine System Drugs Sales Price by Type (2021-2026) & (US$/Pcs) Table 143. China Endocrine System Drugs Sales Price by Type (2027-2032) & (US$/Pcs) Table 144. China Endocrine System Drugs Revenue by Application (2021-2026) & (US$ Million) Table 145. China Endocrine System Drugs Revenue by Application (2027-2032) & (US$ Million) Table 146. China Endocrine System Drugs Sales by Application (2021-2026) & (K Pcs) Table 147. China Endocrine System Drugs Sales by Application (2027-2032) & (K Pcs) Table 148. China Endocrine System Drugs Sales Price by Application (2021-2026) & (US$/Pcs) Table 149. China Endocrine System Drugs Sales Price by Application (2027-2032) & (US$/Pcs) Table 150. Asia Endocrine System Drugs Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Endocrine System Drugs Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Endocrine System Drugs Sales by Type (2021-2026) & (K Pcs) Table 153. Asia Endocrine System Drugs Sales by Type (2027-2032) & (K Pcs) Table 154. Asia Endocrine System Drugs Sales Price by Type (2021-2026) & (US$/Pcs) Table 155. Asia Endocrine System Drugs Sales Price by Type (2027-2032) & (US$/Pcs) Table 156. Asia Endocrine System Drugs Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Endocrine System Drugs Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Endocrine System Drugs Sales by Application (2021-2026) & (K Pcs) Table 159. Asia Endocrine System Drugs Sales by Application (2027-2032) & (K Pcs) Table 160. Asia Endocrine System Drugs Sales Price by Application (2021-2026) & (US$/Pcs) Table 161. Asia Endocrine System Drugs Sales Price by Application (2027-2032) & (US$/Pcs) Table 162. Asia Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Endocrine System Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Asia Endocrine System Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Asia Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 166. Asia Endocrine System Drugs Sales by Country (2021-2026) & (K Pcs) Table 167. Asia Endocrine System Drugs Sales by Country (2027-2032) & (K Pcs) Table 168. Asia Endocrine System Drugs Sales Price by Country (2021-2026) & (US$/Pcs) Table 169. Asia Endocrine System Drugs Sales Price by Country (2027-2032) & (US$/Pcs) Table 170. Japan Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 171. South Korea Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 172. India Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 173. Australia Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 174. China Taiwan Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 175. Southeast Asia Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 176. SAMEA Endocrine System Drugs Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Endocrine System Drugs Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Endocrine System Drugs Sales by Type (2021-2026) & (K Pcs) Table 179. SAMEA Endocrine System Drugs Sales by Type (2027-2032) & (K Pcs) Table 180. SAMEA Endocrine System Drugs Sales Price by Type (2021-2026) & (US$/Pcs) Table 181. SAMEA Endocrine System Drugs Sales Price by Type (2027-2032) & (US$/Pcs) Table 182. SAMEA Endocrine System Drugs Revenue by Application (2021-2026) & (US$ Million) Table 183. SAMEA Endocrine System Drugs Revenue by Application (2027-2032) & (US$ Million) Table 184. SAMEA Endocrine System Drugs Sales by Application (2021-2026) & (K Pcs) Table 185. SAMEA Endocrine System Drugs Sales by Application (2027-2032) & (K Pcs) Table 186. SAMEA Endocrine System Drugs Sales Price by Application (2021-2026) & (US$/Pcs) Table 187. SAMEA Endocrine System Drugs Sales Price by Application (2027-2032) & (US$/Pcs) Table 188. SAMEA Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. SAMEA Endocrine System Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. SAMEA Endocrine System Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. SAMEA Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 192. SAMEA Endocrine System Drugs Sales by Country (2021-2026) & (K Pcs) Table 193. SAMEA Endocrine System Drugs Sales by Country (2027-2032) & (K Pcs) Table 194. SAMEA Endocrine System Drugs Sales Price by Country (2021-2026) & (US$/Pcs) Table 195. SAMEA Endocrine System Drugs Sales Price by Country (2027-2032) & (US$/Pcs) Table 196. Brazil Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 197. Argentina Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 198. Chile Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 199. Colombia Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 200. Peru Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 201. Saudi Arabia Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 202. Israel Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 203. UAE Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 204. Turkey Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 205. Iran Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 206. Egypt Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Endocrine System Drugs Distributors List Table 210. Endocrine System Drugs Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Endocrine System Drugs Image Figure 2. Global Endocrine System Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine System Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Thyroid Hormone Disorder Drugs Image Figure 5. Human Growth Hormones Image Figure 6. Diabetes Drug Image Figure 7. Others Image Figure 8. Global Endocrine System Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Endocrine System Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinics Image Figure 11. Hospitals Image Figure 12. Medical Center Image Figure 13. Others Image Figure 14. Global Endocrine System Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Endocrine System Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global Endocrine System Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Endocrine System Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Endocrine System Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global Endocrine System Drugs Sales (2021-2032) & (K Pcs) Figure 20. Global Endocrine System Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 21. Global Endocrine System Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Endocrine System Drugs Sales YoY (2021-2032) & (K Pcs) Figure 23. Europe Endocrine System Drugs Sales YoY (2021-2032) & (K Pcs) Figure 24. China Endocrine System Drugs Sales YoY (2021-2032) & (K Pcs) Figure 25. Asia (Excluding China) Endocrine System Drugs Sales YoY (2021-2032) & (K Pcs) Figure 26. South America, Middle East and Africa Endocrine System Drugs Sales YoY (2021-2032) & (K Pcs) Figure 27. Global Endocrine System Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Endocrine System Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Endocrine System Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Endocrine System Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Endocrine System Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global Endocrine System Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 34. Global Endocrine System Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Endocrine System Drugs Sales Market Share by Type (2021-2032) Figure 36. Global Endocrine System Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Endocrine System Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Endocrine System Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global Endocrine System Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 40. Global Endocrine System Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Endocrine System Drugs Sales Market Share by Application (2021-2032) Figure 42. North America Endocrine System Drugs Revenue Share by Type (2021-2032) Figure 43. North America Endocrine System Drugs Sales Share by Type (2021-2032) Figure 44. North America Endocrine System Drugs Revenue Share by Application (2021-2032) Figure 45. North America Endocrine System Drugs Sales Share by Application (2021-2032) Figure 46. North America Endocrine System Drugs Revenue Share by Country (2021-2032) Figure 47. North America Endocrine System Drugs Sales Share by Country (2021-2032) Figure 48. Europe Endocrine System Drugs Revenue Share by Type (2021-2032) Figure 49. Europe Endocrine System Drugs Sales Share by Type (2021-2032) Figure 50. Europe Endocrine System Drugs Revenue Share by Application (2021-2032) Figure 51. Europe Endocrine System Drugs Sales Share by Application (2021-2032) Figure 52. Europe Endocrine System Drugs Revenue Share by Country (2021-2032) Figure 53. Europe Endocrine System Drugs Sales Share by Country (2021-2032) Figure 54. China Endocrine System Drugs Revenue Share by Type (2021-2032) Figure 55. China Endocrine System Drugs Sales Share by Type (2021-2032) Figure 56. China Endocrine System Drugs Revenue Share by Application (2021-2032) Figure 57. China Endocrine System Drugs Sales Share by Application (2021-2032) Figure 58. Asia Endocrine System Drugs Revenue Share by Type (2021-2032) Figure 59. Asia Endocrine System Drugs Sales Share by Type (2021-2032) Figure 60. Asia Endocrine System Drugs Revenue Share by Application (2021-2032) Figure 61. Asia Endocrine System Drugs Sales Share by Application (2021-2032) Figure 62. Asia Endocrine System Drugs Revenue Share by Country (2021-2032) Figure 63. Asia Endocrine System Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA Endocrine System Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA Endocrine System Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA Endocrine System Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA Endocrine System Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA Endocrine System Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA Endocrine System Drugs Sales Share by Country (2021-2032) Figure 70. Endocrine System Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Endocrine System Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Thyroid Hormone Disorder Drugs
  • Human Growth Hormones
  • Diabetes Drug
  • Others
Applications
  • Clinics
  • Hospitals
  • Medical Center
  • Others
Companies covered
  • Sanofi
  • Merck
  • Eli Lilly
  • AbbVie
  • AstraZeneca
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endocrine System Drugs Market by Type
  3. 1.2.1 Global Endocrine System Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Thyroid Hormone Disorder Drugs
  5. 1.2.3 Human Growth Hormones
  6. 1.2.4 Diabetes Drug
  7. 1.2.5 Others
  8. 1.3 Endocrine System Drugs Market by Application
  9. 1.3.1 Global Endocrine System Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinics
  11. 1.3.3 Hospitals
  12. 1.3.4 Medical Center
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Endocrine System Drugs Market Dynamics
  1. 2.1 Endocrine System Drugs Industry Trends
  2. 2.2 Endocrine System Drugs Industry Drivers
  3. 2.3 Endocrine System Drugs Industry Opportunities and Challenges
  4. 2.4 Endocrine System Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Endocrine System Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Endocrine System Drugs Revenue by Region
  3. 3.2.1 Global Endocrine System Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endocrine System Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Endocrine System Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Endocrine System Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Endocrine System Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Endocrine System Drugs Sales by Region
  9. 3.4.1 Global Endocrine System Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Endocrine System Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Endocrine System Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Endocrine System Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Endocrine System Drugs Revenue by Manufacturers
  2. 4.1.1 Global Endocrine System Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Endocrine System Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Endocrine System Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endocrine System Drugs Sales by Manufacturers
  6. 4.2.1 Global Endocrine System Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Endocrine System Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Endocrine System Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Endocrine System Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Endocrine System Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Endocrine System Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Endocrine System Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Endocrine System Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Endocrine System Drugs Market CR5 and HHI
  16. 4.8.2 2025 Endocrine System Drugs Tier 1, Tier 2, and Tier 3
5 Endocrine System Drugs Market by Type
  1. 5.1 Global Endocrine System Drugs Revenue by Type
  2. 5.1.1 Global Endocrine System Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Endocrine System Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Endocrine System Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Endocrine System Drugs Sales by Type
  6. 5.2.1 Global Endocrine System Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endocrine System Drugs Sales by Type (2021-2032) & (K Pcs)
  8. 5.2.3 Global Endocrine System Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Endocrine System Drugs Price by Type
6 Endocrine System Drugs Market by Application
  1. 6.1 Global Endocrine System Drugs Revenue by Application
  2. 6.1.1 Global Endocrine System Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Endocrine System Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Endocrine System Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Endocrine System Drugs Sales by Application
  6. 6.2.1 Global Endocrine System Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Endocrine System Drugs Sales by Application (2021-2032) & (K Pcs)
  8. 6.2.3 Global Endocrine System Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Endocrine System Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Endocrine System Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Endocrine System Drugs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Endocrine System Drugs Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 AbbVie
  20. 7.4.1 AbbVie Company Information
  21. 7.4.2 AbbVie Business Overview
  22. 7.4.3 AbbVie Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AbbVie Endocrine System Drugs Product Portfolio
  24. 7.4.5 AbbVie Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Endocrine System Drugs Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Novo Nordisk
  32. 7.6.1 Novo Nordisk Company Information
  33. 7.6.2 Novo Nordisk Business Overview
  34. 7.6.3 Novo Nordisk Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novo Nordisk Endocrine System Drugs Product Portfolio
  36. 7.6.5 Novo Nordisk Recent Developments
8 North America
  1. 8.1 North America Endocrine System Drugs Market Size by Type
  2. 8.1.1 North America Endocrine System Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Endocrine System Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Endocrine System Drugs Price by Type (2021-2032)
  5. 8.2 North America Endocrine System Drugs Market Size by Application
  6. 8.2.1 North America Endocrine System Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Endocrine System Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Endocrine System Drugs Price by Application (2021-2032)
  9. 8.3 North America Endocrine System Drugs Market Size by Country
  10. 8.3.1 North America Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Endocrine System Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Endocrine System Drugs Market Size by Type
  2. 9.1.1 Europe Endocrine System Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Endocrine System Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Endocrine System Drugs Price by Type (2021-2032)
  5. 9.2 Europe Endocrine System Drugs Market Size by Application
  6. 9.2.1 Europe Endocrine System Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Endocrine System Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Endocrine System Drugs Price by Application (2021-2032)
  9. 9.3 Europe Endocrine System Drugs Market Size by Country
  10. 9.3.1 Europe Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Endocrine System Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Endocrine System Drugs Market Size by Type
  2. 10.1.1 China Endocrine System Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Endocrine System Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Endocrine System Drugs Price by Type (2021-2032)
  5. 10.2 China Endocrine System Drugs Market Size by Application
  6. 10.2.1 China Endocrine System Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Endocrine System Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Endocrine System Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endocrine System Drugs Market Size by Type
  2. 11.1.1 Asia Endocrine System Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Endocrine System Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Endocrine System Drugs Price by Type (2021-2032)
  5. 11.2 Asia Endocrine System Drugs Market Size by Application
  6. 11.2.1 Asia Endocrine System Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Endocrine System Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Endocrine System Drugs Price by Application (2021-2032)
  9. 11.3 Asia Endocrine System Drugs Market Size by Country
  10. 11.3.1 Asia Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Endocrine System Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endocrine System Drugs Market Size by Type
  2. 12.1.1 SAMEA Endocrine System Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Endocrine System Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Endocrine System Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Endocrine System Drugs Market Size by Application
  6. 12.2.1 SAMEA Endocrine System Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Endocrine System Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Endocrine System Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Endocrine System Drugs Market Size by Country
  10. 12.3.1 SAMEA Endocrine System Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Endocrine System Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Endocrine System Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Endocrine System Drugs Value Chain Analysis
  2. 13.1.1 Endocrine System Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Endocrine System Drugs Production Mode & Process
  6. 13.2 Endocrine System Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Endocrine System Drugs Distributors
  9. 13.2.3 Endocrine System Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst